Standard Glass Lining Technology IPO Details, Financials, Valuation & Peers
Explore Standard Glass Lining Technology IPO details, including IPO dates, financial statements, valuation, peer comparison and more.
Overview
Standard Glass Lining Technology Limited is a specialized engineering equipment manufacturer for the pharmaceutical and chemical industries in India, ranked among the top five in terms of revenue in Fiscal 2024 (Source: F&S Report). The company offers end-to-end solutions encompassing design, engineering, manufacturing, assembly, installation, and commissioning for turnkey projects. The product portfolio includes core equipment such as reaction systems, storage, separation, drying systems, and plant engineering services. Standard Glass Lining Technology is also one of India’s top three manufacturers of glass-lined, stainless steel, and nickel alloy-based equipment and a key supplier of PTFE-lined pipelines and fittings. With a proven track record of delivering over 11,000 products, the company caters to diverse industries, including pharmaceuticals, chemicals, food and beverage, biotechnology, and fertilizers. Headquartered in Hyderabad, Telangana, the company operates eight manufacturing facilities and maintains a robust sales and distribution network across India and international markets, serving a marquee customer base that includes 30 NSE 500 companies.
Key Points:
- Business Expertise:
- Specializes in engineering solutions for pharmaceuticals, chemicals, biotechnology, food and beverage, and fertilizers.
- Provides turnkey solutions with custom equipment for processes like vacuum distillation, solvent recovery, and gas dispersion.
- Product Categories:
- Reaction Systems: Essential for chemical and pharmaceutical manufacturing.
- Storage, Separation, and Drying Systems: Core equipment for production processes.
- Plant Engineering and Services: Comprehensive support, including ancillary parts.
- Customer Base:
- Serves industries like pharmaceuticals, chemicals, paints, food and beverages, and biotechnology.
- Customers include prominent names like Aurobindo Pharma, Laurus Labs, Granules India, Cadila Pharmaceuticals, and Natco Pharma.
- Manufacturing Strength:
- Eight manufacturing facilities spanning over 400,000 sq. ft. in Hyderabad, Telangana – the “Pharma Hub” of India.
- Sales and Distribution Network:
- Offices in Vadodara, Ankleshwar, Mumbai, and Vishakhapatnam with sales teams across major cities in India.
- International presence with agency agreements in Bangladesh and distribution arrangements in North America, South America, Europe, Asia, and Africa.
Objects of the Issue
- Funding of capital expenditure requirements of the Company towards purchase of machinery and equipment
- Repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the Company and investment in the wholly owned Material Subsidiary, S2 Engineering Industry Private Limited, for repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by S2 Engineering Industry Private Limited, from banks and financial institutions
- Investment in the wholly owned Material Subsidiary, S2 Engineering Industry Private Limited, for funding its capital expenditure requirements towards purchase of machinery and equipment
- Funding inorganic growth through strategic investments and/or acquisitions
- General corporate purposes.
IPO Details
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
| Fields | Details |
|---|---|
| IPO Dates | 06 Jan - 08 Jan 2025 |
| IPO Price Band | ₹133 - ₹140 per share |
| Fresh Issue | ₹210 crore |
| Offer For Sale | 14,289,367 shares (₹200.05 crore) |
| Total IPO Size | ₹410.05 crore |
| Face Value | ₹10 |
| Listing On | BSE, NSE |
IPO Timeline
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
| Event | Date |
|---|---|
| IPO Opening Date | 06 Jan 2025 |
| IPO Closing Date | 08 Jan 2025 |
| Basis Of Allotment | 09 Jan 2025 |
| Refunds | 10 Jan 2025 |
| Demat Transfer | 10 Jan 2025 |
| IPO Listing Date | 13 Jan 2025 |
Financial Statements
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
| Period Ended | 31st March 2022 | 31st March 2023 | 31st March 2024 | Sep 2024 |
|---|---|---|---|---|
| Total Income | 241.50 | 500.08 | 549.68 | 312.10 |
| Total Expenses | 207.73 | 428.22 | 469.88 | 262.36 |
| Net Profit/Loss | 25.15 | 53.42 | 60.01 | 36.27 |
| NPM (*) | 10.41 | 10.68 | 10.92 | 11.62 |
| Total Assets | 298.11 | 347.79 | 665.38 | 756.52 |
| Total Liabilities | 229.15 | 192.07 | 256.40 | 309.67 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Valuation
Uncover significant valuation metrics such as EPS (Earnings Per Share), ROE (Return on Equity), ROCE (Return on Capital Employed), D/E Ratio (Debt-to-Equity Ratio), Current Ratio, and EBITDA Margin. These key indicators offer insights into the company's financial standing and performance, aiding in informed investment decisions.
| Period Ended | 31st March 2022 | 31st March 2023 | 31st March 2024 | Sep 2024 |
|---|---|---|---|---|
| EPS | 2.22 | 3.49 | 3.52 | 1.89 |
| ROE (%) | 54.89 | 47.56 | 20.74 | 8.06 |
| ROCE (%) | 42.03 | 43.43 | 25.49 | 10.81 |
| D/E Ratio | 1.01 | 0.53 | 0.32 | 0.39 |
| Current Ratio | 1.17 | 1.57 | 2.31 | 2.15 |
| EBITDA MARGIN (%) | 17.30 | 17.65 | 18.36 | 20.09 |
* Compiled from DRHP/RHP for valuation purposes.
Peer Comparison
Compare key financial metrics with industry peers to gain valuable insights into the company's performance compared to its competitors.
| Name | Revenue | P/E | EPS | RoNW | NAV |
|---|---|---|---|---|---|
| Standard Glass Lining Technology | 543.67 | 39.77 | 3.52 | 20.74 | 24.55 |
| GMM Pfaudler Ltd | 3,446.48 | 30.64 | 39.80 | 20.23 | 215.22 |
| HLE Glascoat Ltd | 967.92 | 56.54 | 6.52 | 7.99 | 61.06 |
| Thermax Ltd | 9,323.46 | 81.24 | 57.30 | 15.53 | 394.10 |
| Praj Industries | 3,466.28 | 52.54 | 15.42 | 24.09 | 69.36 |
* Revenue in (₹cr), RoNW in (%), EPS, NAV in (₹). P/E ratio is based on the highest price from the IPO price band.
IPO Reservation
| Investor Type | Shares Offered |
|---|---|
| Qualified Institutional Buyer (QIB) | Not more than 50% |
| Non-Institutional Investor (NII/HNI) | Not less than 15% |
| Retail Individual Investor (RII) | Not less than 35% |
Subscription Data from NSE and BSE
| Investor Type | Subscribed |
|---|---|
| Qualified Institutional Buyer (QIB) | 327.76 |
| Non-Institutional Investor (NII/HNI) | 275.21 |
| Retail Individual Investor (RII) | 65.71 |
| Total | 185.48 |
* All figures represent multiples of the subscription. Check subscriptions for other ongoing issues here.
IPO Registrar
KFin Technologies Limited
Phone: +91 40 6716 2222/ 18003094001
Email: einward.ris@kfintech.com
Website: www.kfintech.com
Company Promoters
- NAGESWARA RAO KANDULA
- KANDULA KRISHNA VENI
- KANDULA RAMAKRISHNA
- VENKATA MOHANA RAO KATRAGADDA
- KUDARAVALLI PUNNA RAO
- M/S S2 ENGINEERING SERVICES
Lead Managers
- IIFL Capital Services Limited
- Motilal Oswal Investment Advisors Limited
Company Address
Standard Glass Lining Technology Limited
D.12, Phase-1, IDA Jeedimetla, Hyderabad, Telangana500055, India
Phone: + 040 3518 2204
Email: corporate@standardglr.com
Website: www.standardglr.com
FAQs
- What is the issue size of the Standard Glass Lining Technology IPO?The Standard Glass Lining Technology IPO has an issue size of ₹410.05 crore. This includes a fresh issue of ₹210 crore and an offer for sale (OFS) of 14,289,367 shares (₹200.05 crore).
- What is the price band of the Standard Glass Lining Technology IPO?The price band for the Standard Glass Lining Technology IPO is ₹133 - ₹140 per share.
- What are the bidding dates for the Standard Glass Lining Technology IPO?The Standard Glass Lining Technology IPO will open for bidding on 06 Jan 2025 and close on 08 Jan 2025.
- What is the allotment date for the Standard Glass Lining Technology IPO?The allotment date for the Standard Glass Lining Technology IPO is 09 Jan 2025.
- What is the minimum lot size and investment required for the Standard Glass Lining Technology IPO?The minimum lot size for the Standard Glass Lining Technology IPO is 107 shares and the minimum investment required is ₹14,980.
- What is the listing date for the Standard Glass Lining Technology IPO?The listing date for the Standard Glass Lining Technology IPO is 13 Jan 2025.
- What is the Standard Glass Lining Technology IPO grey market premium?The grey market premium (GMP) for the Standard Glass Lining Technology IPO is currently at ₹50, with an expected listing gain of approximately 35.71%. Remember, the grey market premium is not an official indicator, but it reflects market perception and demand for the IPO shares.